{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal stromal",
            "NStudiesAvail": 430108,
            "NStudiesFound": 326,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 326,
            "FieldList": [
                  "MaximumAge",
                  "MinimumAge",
                  "NCTId",
                  "NCTIdAlias",
                  "OfficialTitle",
                  "OrgClass",
                  "OrgFullName",
                  "OrgStudyId",
                  "OrgStudyIdDomain",
                  "OrgStudyIdLink",
                  "OrgStudyIdType",
                  "OtherEventAssessmentType",
                  "OtherEventNotes",
                  "OtherEventOrganSystem",
                  "OtherEventSourceVocabulary"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01589549"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 2 Trial of Standard of Care Treatment Versus Mesenchymal Stromal Cell Therapy Together With Standard of Care for the Treatment of de Novo Acute Graft Versus Host Disease Following Allogeneic Bone Marrow Transplantation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Royal Perth Hospital"
                        ],
                        "OrgStudyId": [
                              "2011/128"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 2,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02387151"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety of Allogeneic Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Leiden University Medical Center"
                        ],
                        "OrgStudyId": [
                              "NL4724400013"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 3,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03509870"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Uncontrolled Non-randomised Single Dose Study of Topically Applied Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells (REDDSTAR (ORBCEL-M)) in Patients With Non-healing Neuroischaemic Diabetic Foot Wounds'"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Steno Diabetes Center Copenhagen"
                        ],
                        "OrgStudyId": [
                              "2015-005580-16"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 4,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04447833"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome Validation of Mechanistic Pathways and Clinical Efficacy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Uppsala University"
                        ],
                        "OrgStudyId": [
                              "2020-02238"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 5,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02057965"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Combination With Everolimus to Preserve Renal Structure and Function in Renal Recipients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Leiden University Medical Center"
                        ],
                        "OrgStudyId": [
                              "NL43712.000.13"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 6,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01090817"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Multicentre Australian Phase 2 Study to Evaluate Safety and Efficacy of Mesenchymal Stromal Cells for Treating Biologic Refractory Crohn's Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Royal Perth Hospital"
                        ],
                        "OrgStudyId": [
                              "EC2009/123"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 7,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01522716"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Karolinska Institutet"
                        ],
                        "OrgStudyId": [
                              "MSC-cGVH"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 8,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02097641"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) for the Treatment of Acute Respiratory Distress Syndrome (ARDS)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of California, San Francisco"
                        ],
                        "OrgStudyId": [
                              "UCSF-hMSC-ARDS-P2"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Hepatobiliary disorders",
                              "Renal and urinary disorders",
                              "Vascular disorders",
                              "Blood and lymphatic system disorders"
                        ],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 9,
                        "MaximumAge": [
                              "22 Years"
                        ],
                        "MinimumAge": [
                              "12 Years"
                        ],
                        "NCTId": [
                              "NCT02150551"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Children's National Research Institute"
                        ],
                        "OrgStudyId": [
                              "STOMP"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 10,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02012153"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Mesenchymal Stromal Cells to Induce Tolerance in Living-donor Kidney Transplant Recipients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mario Negri Institute for Pharmacological Research"
                        ],
                        "OrgStudyId": [
                              "MSC-Tx tolerance"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 11,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03042572"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs; A Double-blind, Randomized, Placebo-controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "UMC Utrecht"
                        ],
                        "OrgStudyId": [
                              "NL59038.000.16"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 12,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03818854"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) for the Treatment of Acute Respiratory Distress Syndrome"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of California, San Francisco"
                        ],
                        "OrgStudyId": [
                              "UCSF-hMSC-ARDS-P1P2-12"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 13,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02323789"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II Study Evaluating Allogeneic Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "King's College London"
                        ],
                        "OrgStudyId": [
                              "ADSTEM001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 14,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT02032446"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC) FOR THE TREATMENT OF SEVERE (GRADE III-IV) STEROID-RESISTANT GRAFT VERSUS HOST DISEASE (GvHD): A PHASE I/II TRIAL"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "A.O. Ospedale Papa Giovanni XXIII"
                        ],
                        "OrgStudyId": [
                              "EudraCT 2012-000582-21"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 15,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03461458"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study Evaluating the Safety and Feasibility of Autologous, Culture-Expanded Adipose-Derived Mesenchymal Stromal Cells in Subjects With Painful Degenerative Disc Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "17-002136"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 16,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03478215"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Double-blind, Randomized, Controlled Dose Escalation Trial of Autologuous Mesenchymal Stromal Cells in Living Donor Kidney Transplant Recipients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The Methodist Hospital Research Institute"
                        ],
                        "OrgStudyId": [
                              "Pro00012858"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 17,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05286255"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Tolerability of Allogeneic Umbilical Cord Derived Mesenchymal Stromal Cells (UC-MSCs) to Limit COVID Associated ComplicatioNs: An Open Label, Phase 1 Study in Hospitalized Patients (SAMPSON-1)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Medical University of South Carolina"
                        ],
                        "OrgStudyId": [
                              "115966"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 18,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT00644410"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Single Centre, Randomised Controlled Study of the Effect of NOGA-guided Direct Intramyocardial Injection of Mesenchymal Stromal Cells on the Development of New Myocardium and Blood Vessels in Patients With Heart Failure"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Rigshospitalet, Denmark"
                        ],
                        "OrgStudyId": [
                              "MSC heart failure"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 19,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03268603"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II Study of Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "15-008008"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 20,
                        "MaximumAge": [
                              "19 Years"
                        ],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT01061099"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Pilot Study to Assess the Safety and Feasibility of Repeated Infusions of Mesenchymal Stromal Cells (MSC) in Children With Osteogenesis Imperfecta"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Nationwide Children's Hospital"
                        ],
                        "OrgStudyId": [
                              "2008-4-5947"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 21,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT01764100"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cells (MSC) for the Treatment of Severe (Grade II-IV) Steroid-resistant Graft Versus Host Disease (GVHD): a Phase I Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Azienda Ospedaliera San Gerardo di Monza"
                        ],
                        "OrgStudyId": [
                              "PTC-MSC"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 22,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02215811"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Karolinska University Hospital"
                        ],
                        "OrgStudyId": [
                              "MSC-ARDS"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 23,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "14 Years"
                        ],
                        "NCTId": [
                              "NCT02291770"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells. A Phase III Randomized Open Label Multi-center Study in Southern China."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial People's Hospital"
                        ],
                        "OrgStudyId": [
                              "No.GRDEC 2014210H"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 24,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04445454"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Liege"
                        ],
                        "OrgStudyId": [
                              "TJT2012"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 25,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02814864"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Phase II Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Assistance Publique - H\u00f4pitaux de Paris"
                        ],
                        "OrgStudyId": [
                              "P130935"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 26,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03211793"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cells for Angiogenesis and Neovascularisation in Digital Ulcers of Systemic Sclerosis: the MANUS Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "UMC Utrecht"
                        ],
                        "OrgStudyId": [
                              "MANUS"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 27,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02805855"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Feasibility of Autologous Culture Expanded Adipose Derived Mesenchymal Stromal Cells in the Treatment of Painful Knee Osteoarthritis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "15-008179"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 28,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04626583"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells for Promoting Corneal Repair"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Illinois at Chicago"
                        ],
                        "OrgStudyId": [
                              "2020-0334"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 29,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04466098"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Multi-center, Randomized, Placebo Controlled, Interventional Phase 2A Clinical Trial Evaluating the Safety and Potential Efficacy of Multiple Dosing of Mesenchymal Stromal Cells in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Masonic Cancer Center, University of Minnesota"
                        ],
                        "OrgStudyId": [
                              "2020LS075"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 30,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT03233074"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Centre Hospitalier Universitaire de Saint Etienne"
                        ],
                        "OrgStudyId": [
                              "2017-0701"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 31,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04345601"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Single Donor Banked Bone Marrow Mesenchymal Stromal Cells for the Treatment of COVID-19 Induced ARDS: A Non-Blinded Randomized, Controlled Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Baylor College of Medicine"
                        ],
                        "OrgStudyId": [
                              "H-47561 MSC for COVID-19"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 32,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT01038596"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Proliferation and Osteogenic Differentiation of Bone Marrow-derived Mesenchymal Stromal Cells From Osteoarthritic Versus Healthy Donors"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Technische Universit\u00e4t Dresden"
                        ],
                        "OrgStudyId": [
                              "HipMSC-Osteoarthritis"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 33,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04356287"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I/II Randomized Controlled Trial of Umbilical Cord-derived mesenChymAl stRomal cElls in Systemic Sclerosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Sir Mortimer B. Davis - Jewish General Hospital"
                        ],
                        "OrgStudyId": [
                              "MP-05-2020-2251"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 34,
                        "MaximumAge": [
                              "20 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04549285"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Pilot Study of the Safety of Infusions of Allogeneic Human Cord Tissue Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome in Children (MIS-C)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "Pro00106044"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 35,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04348461"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Two-treatment,Randomized, Controlled, Multicenter Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cells in Critically Ill Patients COVID-19"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Instituto de Investigaci\u00f3n Sanitaria de la Fundaci\u00f3n Jim\u00e9nez D\u00edaz"
                        ],
                        "OrgStudyId": [
                              "BALMYS-19"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 36,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03608631"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "M.D. Anderson Cancer Center"
                        ],
                        "OrgStudyId": [
                              "2018-0126"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 37,
                        "MaximumAge": [
                              "17 Years"
                        ],
                        "MinimumAge": [
                              "12 Years"
                        ],
                        "NCTId": [
                              "NCT03014219"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "15-005574"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 38,
                        "MaximumAge": [
                              "6 Months"
                        ],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04236479"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cells Delivery Through Cardiopulmonary Bypass in Pediatric Cardiac Surgery"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Children's National Research Institute"
                        ],
                        "OrgStudyId": [
                              "Pro00011914"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 39,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01659762"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stromal (MSC) Cells in Adults With Moderate to Severe Crohn's Disease."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Emory University"
                        ],
                        "OrgStudyId": [
                              "IRB00051454"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 40,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02646007"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation for Human Avascular Necrosis of the Lunate Bone of the Wrist (Kienbock's Disease)"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royan-Bone-014"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 41,
                        "MaximumAge": [
                              "21 Days"
                        ],
                        "MinimumAge": [
                              "7 Days"
                        ],
                        "NCTId": [
                              "NCT04255147"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Helping Underdeveloped Lungs With Cells (HULC): Mesenchymal Stromal Cells in Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia - Phase 1 Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Ottawa Hospital Research Institute"
                        ],
                        "OrgStudyId": [
                              "HULC-1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 42,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02580695"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Randomized, Double-blind, Controlled Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UC-MSCs) in Patients With Knee Osteoarthritis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad de los Andes, Chile"
                        ],
                        "OrgStudyId": [
                              "C4COA01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 43,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT01175655"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "The Prince Charles Hospital"
                        ],
                        "OrgStudyId": [
                              "EC 28105"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 44,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02565459"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Third-party Bone Marrow-derived Mesenchymal Stromal Cells to Induce Tolerance in Recipients of Kidney Transplants From Deceased Donors (Phase A)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "A.O. Ospedale Papa Giovanni XXIII"
                        ],
                        "OrgStudyId": [
                              "Third-party MSC-Tx tolerance A"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 45,
                        "MaximumAge": [
                              "21 Years"
                        ],
                        "MinimumAge": [
                              "7 Years"
                        ],
                        "NCTId": [
                              "NCT05061030"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Double-blinded, Randomized, Parallel, Placebo-controlled Trial of Wharton's Jelly-derived Allogeneic Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Uppsala University Hospital"
                        ],
                        "OrgStudyId": [
                              "WJMSC-P01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 46,
                        "MaximumAge": [
                              "41 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03973827"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "An Open Label, Parallel Single Center Trial of Wharton's Jelly Derived Allogeneic Mesenchymal Stromal Cells Repeatedly Treated to Preserve Endogenous Insulin Production in Adult Patients Diagnosed With Type 1 Diabetes"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "NextCell Pharma Ab"
                        ],
                        "OrgStudyId": [
                              "ProTrans-Repeat"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 47,
                        "MaximumAge": [
                              "25 Years"
                        ],
                        "MinimumAge": [
                              "1 Year"
                        ],
                        "NCTId": [
                              "NCT00957931"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Pilot Study MUD HCT:Pts High Risk Sickle Cell,Other Non-Malignant RBC Disorders- Reduced Intensity Preparative Regimen, HAPLO-Identical Mesenchymal Stromal Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Stanford University"
                        ],
                        "OrgStudyId": [
                              "MSC01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 48,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03917797"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Dose-response and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Renal Systemic Lupus Erythematosus"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad de los Andes, Chile"
                        ],
                        "OrgStudyId": [
                              "Phase II Lupus MSC"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 49,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04467047"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Feasibility of Allogenic Mesenchymal Stromal Cells in the Treatment of COVID-19"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Hospital de Clinicas de Porto Alegre"
                        ],
                        "OrgStudyId": [
                              "20200148"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 50,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04615429"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Double-blind, Randomized, Controlled, Clinical Trial to Assess the Efficacy of Allogenic Mesenchymal Stromal Cells in Patients With Acute Respiratory Distress Syndrome Due to COVID-19"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Puerta de Hierro University Hospital"
                        ],
                        "OrgStudyId": [
                              "COVID-AT"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 51,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01872624"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Bone-marrow Derived Mesenchymal Stromal Cells Associated With One-way Endobronchial Valves in Patients With Pulmonary Emphysema: Safety Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Hospital de Clinicas de Porto Alegre"
                        ],
                        "OrgStudyId": [
                              "13-0150"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 52,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02421484"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Cellular Immunotherapy for Septic Shock: A Phase I Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Ottawa Hospital Research Institute"
                        ],
                        "OrgStudyId": [
                              "2014809"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 53,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "1 Year"
                        ],
                        "NCTId": [
                              "NCT04328714"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Interferon \u03b3-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease After Allogeneic Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies and Myelodysplasia"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Emory University"
                        ],
                        "OrgStudyId": [
                              "IRB00105305"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 54,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01742260"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Pilot Study to Demonstrate Safety and Feasibility of Cranial Reconstruction Using Mesenchymal Stromal Cells and Resorbable Biomaterials"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Royal Perth Hospital"
                        ],
                        "OrgStudyId": [
                              "2012/047"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 55,
                        "MaximumAge": [
                              "30 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05035862"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 1 Study to Evaluate Safety, Toxicity, and Potential Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Emory University"
                        ],
                        "OrgStudyId": [
                              "STUDY00002655"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 56,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02230514"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase IIa, Single Center, Prospective, Randomized, Parallel, Two-arms, Single-dose, Open-label With Blinded Assessor Pilot Clinical Trial to Assess ex Vivo Expanded Adult Autologous Mesenchymal Stromal Cells Fixed in Allogeneic Bone Tissue (XCEL-MT-OSTEO-ALPHA) in Non Hypertrophic Pseudoarthrosis of Long Bones"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Banc de Sang i Teixits"
                        ],
                        "OrgStudyId": [
                              "XCEL-PSART-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 57,
                        "MaximumAge": [
                              "10 Years"
                        ],
                        "MinimumAge": [
                              "3 Years"
                        ],
                        "NCTId": [
                              "NCT05559801"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 1/2 Study to Examine the Safety and Preliminary Efficacy of Mesenchymal Stromal Cells on Linear Growth and Bone Health Parameters in Children With Type 3 Osteogenesis Imperfecta (OI)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Emory University"
                        ],
                        "OrgStudyId": [
                              "STUDY00003434"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 58,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04361942"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Double Blind, Placebo-controlled, Phase II Trial to Evaluate Safety and Efficacy of Allogenic Mesenchymal Stromal Cells MSV_allo for Treatment of Acute Respiratory Failure in Patients With COVID-19 Pneumonia (COVID_MSV)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Red de Terapia Celular"
                        ],
                        "OrgStudyId": [
                              "TerCel_007"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 59,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02260375"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "THIRD-PARTY BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS TO INDUCE TOLERANCE IN LIVER TRANSPLANT RECIPIENTS"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "A.O. Ospedale Papa Giovanni XXIII"
                        ],
                        "OrgStudyId": [
                              "MSC liver transplant tolerance"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 60,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02495766"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Autologous Mesenchymal Stem Cells Derived From Bone Marrow as a Potential Therapeutic Strategy for the Treatment of Multiple Sclerosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Banc de Sang i Teixits"
                        ],
                        "OrgStudyId": [
                              "XCEL-MS-02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 61,
                        "MaximumAge": [
                              "69 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02384018"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow-derived Mesenchymal Stromal Cells in Chronic Pancreatitis Patients Who Undergo Total Pancreatectomy and Islet Autotransplantation."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Medical University of South Carolina"
                        ],
                        "OrgStudyId": [
                              "CCT-BMMSC15-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 62,
                        "MaximumAge": [
                              "40 Years"
                        ],
                        "MinimumAge": [
                              "12 Years"
                        ],
                        "NCTId": [
                              "NCT03298399"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of Mesenchymal Stromal Cells to Promote Stem Cell Engraftment in Patients With Severe Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Emory University"
                        ],
                        "OrgStudyId": [
                              "IRB00090514"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 63,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02943486"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cell Derivatives: a New Alternative and Potential Product for the Treatment of Diabetic Foot Ulcers 1 and 2"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad Aut\u00f3noma de Bucaramanga"
                        ],
                        "OrgStudyId": [
                              "124174455522"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 64,
                        "MaximumAge": [
                              "11 Years"
                        ],
                        "MinimumAge": [
                              "4 Years"
                        ],
                        "NCTId": [
                              "NCT04089579"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "Pro00102894"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 65,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05204329"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Illinois at Chicago"
                        ],
                        "OrgStudyId": [
                              "2021-0754"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 66,
                        "MaximumAge": [
                              "17 Years"
                        ],
                        "MinimumAge": [
                              "12 Years"
                        ],
                        "NCTId": [
                              "NCT03449069"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "17-010539"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 67,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "45 Years"
                        ],
                        "NCTId": [
                              "NCT04918706"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "An Explorative Study for Halting Inflammation in Patients With Emphysema by Administration of Allogeneic Bone Marrow Derived Mesenchymal Stromal Cells."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Leiden University Medical Center"
                        ],
                        "OrgStudyId": [
                              "HEP study"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 68,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02807389"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Complicated Post-surgical Fistulas"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "15-004326"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 69,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02589119"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With High, Transsphincteric Cryptoglandular Perianal Fistulas"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "15-003200"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 70,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03220243"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Rectovaginal Fistulizing Crohn's Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "17-002892"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 71,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "17 Years"
                        ],
                        "NCTId": [
                              "NCT01849237"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Russian Single-center Open Randomized Clinical Trial of the Impact of Mesenchymal Stromal Cells Therapy on Organ Dysfunction and 28-day Mortality in Patients With Septic Shock and Severe Neutropenia."
                        ],
                        "OrgClass": [
                              "NETWORK"
                        ],
                        "OrgFullName": [
                              "National Research Center for Hematology, Russia"
                        ],
                        "OrgStudyId": [
                              "RuMCeSS"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 72,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "12 Years"
                        ],
                        "NCTId": [
                              "NCT02359929"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of Mesenchymal Stromal Cells for the Treatment of Acute and Chronic Graft Versus Host Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Emory University"
                        ],
                        "OrgStudyId": [
                              "IRB00076372"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 73,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04714801"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Danish, Single Centre, Double-blind, Randomized Study Evaluating Allogeneic Adipose Tissue Derived Mesenchymal Stromal Cell Therapy to Reduce Primary Graft Dysfunction After Lung Transplantation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Rigshospitalet, Denmark"
                        ],
                        "OrgStudyId": [
                              "ASC Lungtransplantation"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 74,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT01306513"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effect of Autologous Bone Marrow Derived Mesenchymal Stromal Cells Prior to Lung Volume Reduction Surgery for Severe Pulmonary Emphysema- a Phase I Safety and Feasibility Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Leiden University Medical Center"
                        ],
                        "OrgStudyId": [
                              "NL28562.000.09"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 75,
                        "MaximumAge": [
                              "18 Years"
                        ],
                        "MinimumAge": [
                              "3 Years"
                        ],
                        "NCTId": [
                              "NCT04034316"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 2 Open-label Study to Evaluate the Efficacy of Allogeneic Human Cord Blood-derived Mesenchymal Stromal Cells in Maintaining Remission After Immunosuppressive Therapy Withdrawal in Pediatric Patients With Steroid-dependent Nephrotic Syndrome"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico"
                        ],
                        "OrgStudyId": [
                              "AIFA-2016-02364896"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 76,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04675359"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Comparison of the Treatment Results of Knee Osteoarthritis Using Adipose Tissue Mesenchymal Stromal Cells Derived Through Enzymatic Digestion and Mechanically Fragmented Adipose Tissue"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Medical University of Warsaw"
                        ],
                        "OrgStudyId": [
                              "MSC"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 77,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT01449032"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Rigshospitalet, Denmark"
                        ],
                        "OrgStudyId": [
                              "MyStromalCell"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 78,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04333368"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Assistance Publique - H\u00f4pitaux de Paris"
                        ],
                        "OrgStudyId": [
                              "APHP200395"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 79,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02055625"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Oral Mucosa in Patients With Graft-versus-host Disease Following Injection of Mesenchymal Stem Cells - Human Pilot Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Karolinska Institutet"
                        ],
                        "OrgStudyId": [
                              "2013/1241-31/1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 80,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04525378"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cell-based Therapy for COVID-19-associated Acute Respiratory Distress Syndrome: a Pilot Clinical Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "D'Or Institute for Research and Education"
                        ],
                        "OrgStudyId": [
                              "PCL02/2020"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 81,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03522545"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The University of Texas Health Science Center, Houston"
                        ],
                        "OrgStudyId": [
                              "HSC-MS-16-0657"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 82,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04400032"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Ottawa Hospital Research Institute"
                        ],
                        "OrgStudyId": [
                              "20200243-01H"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 83,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT03810521"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad de los Andes, Chile"
                        ],
                        "OrgStudyId": [
                              "CLT-OA1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 84,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04711200"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cells Treatment in Lyell Syndrome: A Pilot Phase 1-2 Open Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Assistance Publique - H\u00f4pitaux de Paris"
                        ],
                        "OrgStudyId": [
                              "P150941J"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 85,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05283317"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Effect of Mesenchymal Stromal Cells on the Mortality of Patients With Sepsis and Septic Shock: A Promising Therapy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "TC Erciyes University"
                        ],
                        "OrgStudyId": [
                              "Mesenchymal Stromal Cells"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 86,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT05465096"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Interventional Pilot Study on the Treatment of Osteoarthritis of the Hip Joint With Intra-articular Ultrasound-guided Infiltration of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Istituto Ortopedico Rizzoli"
                        ],
                        "OrgStudyId": [
                              "Lipo-Hip"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 87,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT03007576"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Clinical Trial - Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "EMO Biomedicine Corporation"
                        ],
                        "OrgStudyId": [
                              "EMOCT01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 88,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04290182"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "An Open Phase I/II Study in Patients With Dysphonia and Vocal Fold Scarring to Evaluate Safety, Tolerability and Vocal Function After Surgery With Local Administration of Autologous Mesenchymal Stromal Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Karolinska University Hospital"
                        ],
                        "OrgStudyId": [
                              "2019-06160 and 5.1-2019-92069"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 89,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04399889"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Pilot Study of Safety and Efficacy of Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC) in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "Pro00105410"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 90,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03828123"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Prospective, Non-randomized, Open Label Study to Assess the Safety and the Efficacy of Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Bioinova, s.r.o."
                        ],
                        "OrgStudyId": [
                              "AMSC-ALS-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 91,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "12 Years"
                        ],
                        "NCTId": [
                              "NCT04744116"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized Controlled Pilot Study of Two Doses of Cord Blood Tissue-Derived Mesenchymal Stromal Cells Combined With Ruxolitinib Versus Ruxolitinib Alone for Therapy of Steroid-Refractory Acute Graft Versus Host Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "M.D. Anderson Cancer Center"
                        ],
                        "OrgStudyId": [
                              "2019-1122"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 92,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04489732"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Pilot Study of Mesenchymal Stromal Cells in Patients With Xerostomia After Radiation Therapy for Head and Neck Cancer"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Wisconsin, Madison"
                        ],
                        "OrgStudyId": [
                              "2020-1290"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 93,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02709343"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 2 Randomised Controlled Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction (CLAD)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The University of Queensland"
                        ],
                        "OrgStudyId": [
                              "ASSIST-CLAD"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 94,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "19 Years"
                        ],
                        "NCTId": [
                              "NCT03504241"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Donor-derived Mesenchymal Stromal Cells, Alemtuzumab, Co-stimulation Blockade and Sirolimus for Tolerance Induction in Adult Kidney Allograft Recipients (ITN062ST)"
                        ],
                        "OrgClass": [
                              "NIH"
                        ],
                        "OrgFullName": [
                              "National Institute of Allergy and Infectious Diseases (NIAID)"
                        ],
                        "OrgStudyId": [
                              "DAIT ITN062ST"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 95,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05456243"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety of Intraarterial Infusion of Adipose Tissue-derived Mesenchymal Stromal Cells to Treat Antibody-mediated and Cellular Rejection in Adult Kidney Transplant Recipients (AMSCAR)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "21-012522"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 96,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04366830"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Intermediate-size Expanded Access of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells for Acute Respiratory Distress Syndrome Due to COVID-19 Infection"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Mesoblast, Ltd."
                        ],
                        "OrgStudyId": [
                              "MSB-MSC-ARDS001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 97,
                        "MaximumAge": [
                              "64 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04435249"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I/II, Open Label Study to Assess the Safety and Efficacy Autologous Bone Marrow-derived Mesenchymal Stromal Cells Seeded on to Decellularised Airway Scaffold in Subjects With Clinically Significant Bronchopleural Fistula"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Videregen Limited"
                        ],
                        "OrgStudyId": [
                              "UK-2019-004939-24"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 98,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04325594"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Optimization of the Complex Treatment of Nonischemic Dilated Cardiomyopathy Due to the Addition to the Standard Drug Therapy of Intracoronary Administration of Umbilical Cord-derived Mesenchymal Stromal Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The Research-Clinical Center for Cardiac Surgery and Transplantology LLP"
                        ],
                        "OrgStudyId": [
                              "RCCCT 02-02-2020"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 99,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04971161"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Placebo-Controlled, Double-blind, Dose-Ranging, Multicenter, Phase IIb Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Therapy-Resistant Chronic Venous Ulcer (CVU)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "RHEACELL GmbH & Co. KG"
                        ],
                        "OrgStudyId": [
                              "allo-APZ2-CVU-IIb"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 100,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04896853"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Respiratory Complications Associated With COVID-19 Infection Using Wharton's Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans\u00ae): Open Phase IB Clinical Trial"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "NextCell Pharma Ab"
                        ],
                        "OrgStudyId": [
                              "PRO TRANS 19+"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 101,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03209700"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Re-treatment for Partial or Non-responders for a Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Perianal Fistulas"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "17-004503"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 102,
                        "MaximumAge": [
                              "40 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03406585"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Double-blinded, Randomized, Placebo-controlled Trial With Wharton's Jelly Derived Allogeneic Mesenchymal Stromal Cells (WJMSCs) for Preserving Endogenous Insulin Production in Adult Patients Diagnosed for Type 1 Diabetes"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "NextCell Pharma Ab"
                        ],
                        "OrgStudyId": [
                              "ProTrans-T1D"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 103,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT05464381"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Double-blind, Randomized, Placebo-controlled, Interventional, Multicenter, Phase III Clinical Trial to Investigate the Safety and Efficacy of ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs) on Epidermolysis Bullosa (EB)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "RHEACELL GmbH & Co. KG"
                        ],
                        "OrgStudyId": [
                              "allo-APZ2-EB-III"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 104,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01860417"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Lumbar Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Bone Marrow Mesenchymal Stromal Cells Expanded Using the Valladolid IBGM Procedure"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Red de Terapia Celular"
                        ],
                        "OrgStudyId": [
                              "TerCel005"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 105,
                        "MaximumAge": [
                              "17 Years"
                        ],
                        "MinimumAge": [
                              "2 Months"
                        ],
                        "NCTId": [
                              "NCT02336230"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Mesoblast, Ltd."
                        ],
                        "OrgStudyId": [
                              "MSB-GVHD001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Blood and lymphatic system disorders",
                              "Blood and lymphatic system disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Endocrine disorders",
                              "Endocrine disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "Hepatobiliary disorders",
                              "Immune system disorders",
                              "Immune system disorders",
                              "Immune system disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Investigations",
                              "Investigations",
                              "Investigations",
                              "Investigations",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Psychiatric disorders",
                              "Psychiatric disorders",
                              "Psychiatric disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Vascular disorders",
                              "Vascular disorders"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0",
                              "MedDRA 20.0"
                        ]
                  },
                  {
                        "Rank": 106,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02997878"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "An Adaptive,Multicentre, Phase IIa, Multi-disease Trial Investigating the Safety & Activity of a Single Infusion of Selected Mesenchymal Stromal Cells in the Treatment of Patients With Primary Sclerosing Cholangitis & Autoimmune Hepatitis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Birmingham"
                        ],
                        "OrgStudyId": [
                              "RG-13-124"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 107,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01586312"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Mesenchymal Stromal Cells From Valladolid"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Red de Terapia Celular"
                        ],
                        "OrgStudyId": [
                              "TerCel004"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                              "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                              "Surgical and medical procedures",
                              "Skin and subcutaneous tissue disorders",
                              "Reproductive system and breast disorders",
                              "Reproductive system and breast disorders",
                              "Reproductive system and breast disorders",
                              "Reproductive system and breast disorders",
                              "Immune system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Endocrine disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Eye disorders",
                              "Psychiatric disorders",
                              "Psychiatric disorders",
                              "Vascular disorders"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0",
                              "MedDRA v16.0"
                        ]
                  },
                  {
                        "Rank": 108,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04869397"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Respiratory Complications Associated With COVID-19 Infection Using Wharton's Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans\u00ae): a Randomized Phase II Controlled Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "McGill University Health Centre/Research Institute of the McGill University Health Centre"
                        ],
                        "OrgStudyId": [
                              "2021-6954"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 109,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03901235"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Refractory Crohn's Disease Lesions by Local Injection of Mesenchymal Stem Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Liege"
                        ],
                        "OrgStudyId": [
                              "TJT1707P1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 110,
                        "MaximumAge": [
                              "83 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01922908"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "SAfety of Mesenchymal Stromal Cells for Ischemic Stroke"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The University of Texas Health Science Center, Houston"
                        ],
                        "OrgStudyId": [
                              "SAMCIS"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 111,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04341610"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Adipose Tissue Derived Mesenchymal Stromal Cell Therapy for Treating Patients With Severe Respiratory COVID-19. A Danish, Double-blind, Randomized Placebo-controlled Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Rigshospitalet, Denmark"
                        ],
                        "OrgStudyId": [
                              "EudraCT number: 2020-001330-36"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 112,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02270307"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Bone Marrow Transplantation (Allo-BMT) From Human Leukocyte Antigen (HLA) - Identical Related and Unrelated Donors in Patients With Hematological Malignancies With High Risk of Relapse Using Cyclophosphamide (CY) and Mesenchymal Stromal Cells (MSC) as aGVHD Prophylaxis"
                        ],
                        "OrgClass": [
                              "NETWORK"
                        ],
                        "OrgFullName": [
                              "National Research Center for Hematology, Russia"
                        ],
                        "OrgStudyId": [
                              "MSC-CY-Russia"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 113,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02033525"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I-IIa Safety and Efficacy Pilot Clinical Trial of Intraarticular Administration of Autologous Mesenchymal Cells for Meniscus Injury"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Banc de Sang i Teixits"
                        ],
                        "OrgStudyId": [
                              "XCEL-MEN-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 114,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04018729"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Bone Marrow-Derived Mesenchymal Stromal Cell Therapy Associated With Unidirectional Endobronchial Valve in Patients With Severe Pulmonary Emphysema: A Randomized Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Hospital de Clinicas de Porto Alegre"
                        ],
                        "OrgStudyId": [
                              "2018-0327"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 115,
                        "MaximumAge": [
                              "79 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05433298"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Multicenter Phase I/IIa Study of Mesenchymal Stromal Cells for the Treatment of Patients With SARS-CoV-2 Pneumonia."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1"
                        ],
                        "OrgStudyId": [
                              "MSC SARS-CoV-2"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 116,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05095532"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Mesenchymal Stromal Cells and Islet Co-transplantation to Enhance Islet Survival and Function in Chronic Pancreatitis Patients Undergo Total Pancreatectomy and Islet Autotransplantation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Medical University of South Carolina"
                        ],
                        "OrgStudyId": [
                              "Pro00099487"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 117,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02585622"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Novel Stromal Cell Therapy for Diabetic Kidney Disease (NEPHSTROM Study)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mario Negri Institute for Pharmacological Research"
                        ],
                        "OrgStudyId": [
                              "NEPHSTROM"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 118,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02165904"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in Patients Suffering Incomplete Spinal Cord Injury (SCI)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Puerta de Hierro University Hospital"
                        ],
                        "OrgStudyId": [
                              "CME-LEM2"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [
                              "Hypertension",
                              "Local pain",
                              "Leg pain",
                              "Urinary tract infection",
                              "Headache",
                              "Hyperthermia",
                              "Wound",
                              "Infected pressure ulcer",
                              "Arthralgia",
                              "Syncope",
                              "Pain in coccyx",
                              "Neck pain",
                              "Back pain",
                              "Nasopharingytis",
                              "Bronchitis",
                              "Urinary retention"
                        ],
                        "OtherEventOrganSystem": [
                              "Vascular disorders",
                              "General disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Infections and infestations",
                              "Nervous system disorders",
                              "General disorders",
                              "Injury, poisoning and procedural complications",
                              "Infections and infestations",
                              "Musculoskeletal and connective tissue disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Renal and urinary disorders"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)"
                        ]
                  },
                  {
                        "Rank": 119,
                        "MaximumAge": [
                              "39 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT02603744"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluate the Safety and Feasibility of Intra-ovarian Injection of Autologous Adipose Derived Mesenchymal Stromal Cells (ADMSC) in Women With Premature Ovarian Failure(POF)"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Rep-Bio-Royan-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 120,
                        "MaximumAge": [
                              "38 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04815213"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Use of Expanded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans: Phase I Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Jordan"
                        ],
                        "OrgStudyId": [
                              "POF.UJCTC"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 121,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03015623"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Multi-center, Randomized, Sham-controlled, Double-blind, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 Therapy) in Subjects With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Sentien Biotechnologies, Inc."
                        ],
                        "OrgStudyId": [
                              "SBI-101-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 122,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT03651791"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "In Vivo MRI Tracking of Mesenchymal Stromal Cells Labeled With Ultra-Small Paramagnetic Iron Oxide Particles After Intramyocardial Transplantation in Patients With Chronic Ischemic Heart Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Rigshospitalet, Denmark"
                        ],
                        "OrgStudyId": [
                              "USPIO-MSC1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 123,
                        "MaximumAge": [
                              "3 Days"
                        ],
                        "MinimumAge": [
                              "1 Day"
                        ],
                        "NCTId": [
                              "NCT05490173"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare"
                        ],
                        "OrgStudyId": [
                              "ncagp4382277"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 124,
                        "MaximumAge": [
                              "17 Years"
                        ],
                        "MinimumAge": [
                              "1 Year"
                        ],
                        "NCTId": [
                              "NCT05131412"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation: a a Retrospective Cohort Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangzhou Women and Children's Medical Center"
                        ],
                        "OrgStudyId": [
                              "GWCMC_HJ_XY_001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 125,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04445220"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Multi-center, Randomized, Case Controlled, Double-blind, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 Therapy) in COVID-19 Subjects With Acute Kidney Injury Receiving Renal Replacement Therapy"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Sentien Biotechnologies, Inc."
                        ],
                        "OrgStudyId": [
                              "SBI-101-02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 126,
                        "MaximumAge": [
                              "50 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04210440"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Core Decompression With Bone Chips Allograft Adjuvanted by Fibrin Platelet Rich-plasma (PRP) and Concentrated Autologous Mesenchymal Stromal Cells (MSCS): Results in Avascular Necrosis of Femoral Head (AVN) After 2 Years Minimum Follow-up"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Istituto Ortopedico Rizzoli"
                        ],
                        "OrgStudyId": [
                              "0029170"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 127,
                        "MaximumAge": [
                              "17 Years"
                        ],
                        "MinimumAge": [
                              "2 Months"
                        ],
                        "NCTId": [
                              "NCT04456439"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Intermediate-size Expanded Access of Remestemcel-L, Human Mesenchymal Stromal Cells, for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Mesoblast, Ltd."
                        ],
                        "OrgStudyId": [
                              "MSB-MSC-MISC001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 128,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "12 Years"
                        ],
                        "NCTId": [
                              "NCT04629833"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomised, Open-label, Multicentre, Phase 3 Trial of First-line Treatment With Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects With Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "medac GmbH"
                        ],
                        "OrgStudyId": [
                              "MC-MSC.1/aGvHD"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 129,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "45 Years"
                        ],
                        "NCTId": [
                              "NCT02838069"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase IIb, Prospective, Multicentre, Double-blind, Triple-arm, Randomized Versus Placebo Trial, to Assess the Efficacy of a Single Injection of Either 2 or 10 x 106 Autologous Adipose Derived Mesenchymal Stromal Cells (ASC) in the Treatment of Mild to Moderate Osteoarthritis (OA) of the Knee, Active and Unresponsive to Conservative Therapy for at Least 12 Months"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University Hospital, Montpellier"
                        ],
                        "OrgStudyId": [
                              "UF 9494"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 130,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04371393"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Mesenchymal Stromal Cells for the Treatment of Moderate to Severe COVID-19 Acute Respiratory Distress Syndrome"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Icahn School of Medicine at Mount Sinai"
                        ],
                        "OrgStudyId": [
                              "GCO 08-1078-0014"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 131,
                        "MaximumAge": [
                              "14 Years"
                        ],
                        "MinimumAge": [
                              "2 Years"
                        ],
                        "NCTId": [
                              "NCT02382874"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogenic Adipose Derived Mesenchymal Stromal Cells Transplantation to Improve Kidney Function in Refractory Primary Nephrotic Syndrome (Focal Segmental Glomerulosclerosis,FSGS) ,a Phase I Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royan-Kidney-005"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 132,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02448849"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Use of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Combination With Platelet Lysate Product for Human Long Bone Nonunion Treatment, A Phase 2-3 Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royan-Bone-013"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 133,
                        "MaximumAge": [
                              "40 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04397471"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Study to Collect Bone Marrow for Process Development and Production of Bone Marrow Mesenchymal Stromal Cells to Treat Severe COVID19 Pneumonitis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Cambridge University Hospitals NHS Foundation Trust"
                        ],
                        "OrgStudyId": [
                              "COMET20d"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 134,
                        "MaximumAge": [
                              "48 Months"
                        ],
                        "MinimumAge": [
                              "18 Months"
                        ],
                        "NCTId": [
                              "NCT04294290"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "AN OPEN LABEL PHASE I STUDY OF hCT-MSC, AN UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELL PRODUCT IN YOUNG CHILDREN WITH AUTISM SPECTRUM DISORDER"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "Pro00104460"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 135,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03608579"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "ASCLEPIOS Autologous Stem CelL Expansion and Prospective Injection for Osteoarthritic Hip Symptoms"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "18-000015"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 136,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01915927"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 1 Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "12-009716"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 137,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02145923"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effectiveness and Safety of Intravenous Infusion of Bone Marrow Derived Allogeneic Multipotent Mesenchymal Stromal Cells for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis in Hematological Patients With Aplasia After High-dose Chemotherapy."
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Burnasyan Federal Medical Biophysical Center"
                        ],
                        "OrgStudyId": [
                              "RU-FMBC-05-01-14"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 138,
                        "MaximumAge": [
                              "60 Months"
                        ],
                        "MinimumAge": [
                              "24 Months"
                        ],
                        "NCTId": [
                              "NCT03473301"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II Study of Allogeneic Umbilical Cord Blood and Umbilical Cord Tissue-Derived Mesenchymal Stromal Cell Infusions in Children With Cerebral Palsy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "Pro00089362"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Blood and lymphatic system disorders",
                              "Cardiac disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Surgical and medical procedures",
                              "Surgical and medical procedures",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Injury, poisoning and procedural complications",
                              "Nervous system disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Ear and labyrinth disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "Immune system disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Investigations",
                              "Metabolism and nutrition disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Surgical and medical procedures",
                              "Surgical and medical procedures",
                              "Surgical and medical procedures",
                              "Surgical and medical procedures",
                              "Blood and lymphatic system disorders",
                              "General disorders",
                              "General disorders",
                              "Immune system disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "General disorders",
                              "Nervous system disorders",
                              "Psychiatric disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Surgical and medical procedures"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA",
                              "MedDRA"
                        ]
                  },
                  {
                        "Rank": 139,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01909154"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Pilot Study to Evaluate the Security of Local Administration of Autologous Stem Cells Obtained From the Bone Marrow Stroma, in Traumatic Injuries of the Spinal Cord"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Puerta de Hierro University Hospital"
                        ],
                        "OrgStudyId": [
                              "CME-LEM1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Metabolism and nutrition disorders",
                              "General disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Metabolism and nutrition disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Surgical and medical procedures",
                              "Skin and subcutaneous tissue disorders",
                              "Blood and lymphatic system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Psychiatric disorders",
                              "Renal and urinary disorders",
                              "Vascular disorders",
                              "Vascular disorders",
                              "Vascular disorders"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)",
                              "MedDRA (18.1)"
                        ]
                  },
                  {
                        "Rank": 140,
                        "MaximumAge": [
                              "34 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04484077"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A PHASE I STUDY OF hCT-MSC, AN UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELL PRODUCT, IN ADULTS WITH AUTISM SPECTRUM DISORDER"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "PRO00104691"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 141,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT02829216"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Functional Profiling of the Hematopoietic Stem Cell Niche in Graft Versus Host Disease Mediated Bone Marrow Insufficiency"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Technische Universit\u00e4t Dresden"
                        ],
                        "OrgStudyId": [
                              "Bone marrow GvHD"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 142,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02351011"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Human Autologous Mesenchymal Stromal Cells for the Treatment of Mid to Late Stage Knee Osteoarthritis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University Health Network, Toronto"
                        ],
                        "OrgStudyId": [
                              "MSC-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 143,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT00260338"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Rigshospitalet, Denmark"
                        ],
                        "OrgStudyId": [
                              "Jens Kastrup"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 144,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02181478"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Intra-osseous Co-transplant of Cord Blood and Mesenchymal Stromal Cells: A Feasibility Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Case Comprehensive Cancer Center"
                        ],
                        "OrgStudyId": [
                              "CASE1Z14"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 145,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03389919"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "EFFECTIVENESS AND SAFETY OF INTRAOSSEOUS ADMINISTRATION OF MESENCHYMAL STORMAL CELLS FOR PRIMARY GRAFT FAILURE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION"
                        ],
                        "OrgClass": [
                              "NETWORK"
                        ],
                        "OrgFullName": [
                              "National Research Center for Hematology, Russia"
                        ],
                        "OrgStudyId": [
                              "BM-MSC-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 146,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "70 Years"
                        ],
                        "NCTId": [
                              "NCT02630836"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Pilot Clinical Trial of ex Vivo Expanded Allogenic Adult Stem Cells Combined With Allogenic Human Bone Tissue (XCEL-MT-OSTEO-BETA) in Proximal Femur Fractures in Elderly Patients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Banc de Sang i Teixits"
                        ],
                        "OrgStudyId": [
                              "XCEL-MT-10-03"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 147,
                        "MaximumAge": [
                              "11 Years"
                        ],
                        "MinimumAge": [
                              "2 Years"
                        ],
                        "NCTId": [
                              "NCT03099239"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of hCT-MSC, An Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "Pro00079421"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 148,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT01585857"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I, Prospective, Bi-centric,Single -Arm, Open-label, Dose-escalating Clinical Trial to Evaluate the Safety of a Single Injection of Autologous Adipose Derived Mesenchymal Stromal Cells in the Treatment of Severe Osteoarthritis of the Knee Joint"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University Hospital, Montpellier"
                        ],
                        "OrgStudyId": [
                              "8606"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 149,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03113747"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy Evaluation of Tissue Engineered Construct Based on Allogeneic Adipose-derived Multipotent Mesenchymal Stromal Cells and Platelet-poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "A.A. Partners, LLC"
                        ],
                        "OrgStudyId": [
                              "MSC-P1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 150,
                        "MaximumAge": [
                              "16 Years"
                        ],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT05491135"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Hepatocytes Co-Encapsulated With Mesenchymal Stromal Cells in Alginate Microbeads for the Treatment of Acute Liver Failure in Paediatric Patients (HELP)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "King's College Hospital NHS Trust"
                        ],
                        "OrgStudyId": [
                              "3571"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 151,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02706132"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "MSC for ABO Incompatible Liver Transplantation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Third Affiliated Hospital, Sun Yat-Sen University"
                        ],
                        "OrgStudyId": [
                              "2015-08"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 152,
                        "MaximumAge": [
                              "16 Years"
                        ],
                        "MinimumAge": [
                              "6 Years"
                        ],
                        "NCTId": [
                              "NCT04545307"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Transplantation of Allogeneic Mesenchymal Stromal Cells in Patients With Immature Apex Teeth With Pulp Necrosis and Chronic Apical Periodontitis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad Central de Venezuela"
                        ],
                        "OrgStudyId": [
                              "MSCYPPNAP001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 153,
                        "MaximumAge": [
                              "89 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04007081"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Salivary Gland Autotransplantation of Marrow Mesenchymal Stromal Cells for Treatment of Radiation-induced Xerostomia - FDA IND (Investigational New Drug) Enabling Studies"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Wisconsin, Madison"
                        ],
                        "OrgStudyId": [
                              "UW19009"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 154,
                        "MaximumAge": [
                              "81 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01686139"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 1 Study: Treatment of Patients With Diabetic Foot Complications With Allogeneic Bone Marrow Derived Mesenchymal Stromal Cells (ABMD-MSC)"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Sheba Medical Center"
                        ],
                        "OrgStudyId": [
                              "SHEBA-11-8802-IS-SMC"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 155,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01275612"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Ex-Vivo Expanded Mesenchymal Stem Cells To Repair The Kidney And Improve Function In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mario Negri Institute for Pharmacological Research"
                        ],
                        "OrgStudyId": [
                              "CIS/MSC 08"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 156,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05333029"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II Study of Combination Treatment With Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for High-Risk and Steroid-Refractory Acute GVHD"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Case Comprehensive Cancer Center"
                        ],
                        "OrgStudyId": [
                              "CASE1Z20"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 157,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03673748"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Lupus Nephritis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Red de Terapia Celular"
                        ],
                        "OrgStudyId": [
                              "TerCel_006"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 158,
                        "MaximumAge": [
                              "34 Weeks"
                        ],
                        "MinimumAge": [
                              "23 Weeks"
                        ],
                        "NCTId": [
                              "NCT02274428"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 1 Clinical Trial of PNEUMOSTEM\u00ae Treatment in Premature Infants With Intraventricular Hemorrhage"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Samsung Medical Center"
                        ],
                        "OrgStudyId": [
                              "2014-06-103"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 159,
                        "MaximumAge": [
                              "48 Hours"
                        ],
                        "MinimumAge": [
                              "0 Hours"
                        ],
                        "NCTId": [
                              "NCT03635450"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Newborn Infants With Moderate or Severe Hypoxic- Ischemic Neonatal Encephalopathy."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "Pro00100253"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 160,
                        "MaximumAge": [
                              "35 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01463475"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Wisconsin, Madison"
                        ],
                        "OrgStudyId": [
                              "H-2010-0104"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 161,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02409940"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized Trial to Elucidate Effect of Mesenchymal Stem Cells on Immune Modulation in Living Related Kidney Transplant Patients"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Postgraduate Institute of Medical Education and Research"
                        ],
                        "OrgStudyId": [
                              "IFA-LSBM-11"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 162,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "25 Years"
                        ],
                        "NCTId": [
                              "NCT02195323"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Administration of Autologous Bone Marrow Mesenchymal Stem Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royan-Kidney-004"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 163,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03171194"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Safety Trial of Allogeneic Mesenchymal Stem Cells for Systemic Lupus Erythematosus"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Medical University of South Carolina"
                        ],
                        "OrgStudyId": [
                              "00061632"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 164,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02801890"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous AD-MSC Transplantation in Peritoneal Dialysis Patients With Ultra Filtration Failure and Evaluation of Cellular and Molecular Effects of Mesenchymal Stem Cell Infusion on Peritoneal Fibrosis"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royan-kidney-006"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 165,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT04466007"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Multicenter, Randomized, Dose-search, Parallel, Double-blind, and Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Intramuscular Administration of Allogeneic Adipose Tissue Adult Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia Without Possibility of Revascularization"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Instituto de Investigaci\u00f3n Sanitaria de la Fundaci\u00f3n Jim\u00e9nez D\u00edaz"
                        ],
                        "OrgStudyId": [
                              "NOMA (No More Amputations)"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 166,
                        "MaximumAge": [
                              "10 Days"
                        ],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT03356821"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Adult Mesenchymal Stromal Cells to Regenerate the Neonatal Brain: the PASSIoN Trial (Perinatal Arterial Stroke Treated With Stromal Cells IntraNasally)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "UMC Utrecht"
                        ],
                        "OrgStudyId": [
                              "NL59265.000.16"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 167,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03909139"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Prospective PROMs Outcomes in Arthroscopic Acetabular Labral Repair With and Without Application of Platelet-Rich Plasma (PRP) Harvested From the Body of the Ilium"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Massachusetts General Hospital"
                        ],
                        "OrgStudyId": [
                              "2019P002191"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 168,
                        "MaximumAge": [
                              "50 Years"
                        ],
                        "MinimumAge": [
                              "14 Years"
                        ],
                        "NCTId": [
                              "NCT02247973"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase\u2161Trial of Co-transplantation With Bone Marrow Derived Mesenchymal Stem Cells From Related Donors in Alternative Donor Transplantation of Severe Aplastic Anemia."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangzhou General Hospital of Guangzhou Military Command"
                        ],
                        "OrgStudyId": [
                              "MSC-alternative donor SCT-SAA"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 169,
                        "MaximumAge": [
                              "35 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02940418"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Use of Mesenchymal Stromal Cells (MSC) in Type 1 Diabetes Mellitus in Adult Humans: Phase I Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Jordan"
                        ],
                        "OrgStudyId": [
                              "T1DM.UJCTC"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 170,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT01840540"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "12-009298"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 171,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04247945"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Co-transplantation of Mesenchymal Stromal Cells in Allogeneic Hematopoietic Stem Cell Transplantation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Fujian Medical University"
                        ],
                        "OrgStudyId": [
                              "MSC-SCT-03"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 172,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03369275"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Cellular Immunotherapy for Septic Shock (CISS2) A Phase II Randomized Controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Ottawa Hospital Research Institute"
                        ],
                        "OrgStudyId": [
                              "201706"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 173,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02408432"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "M.D. Anderson Cancer Center"
                        ],
                        "OrgStudyId": [
                              "2014-0519"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 174,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT05060107"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study Aiming to Assess Safety and Efficacy of a Single Intra-articular Injection of MSC-derived Exosomes (CelliStem\u00aeOA-sEV) in Patients With Moderate Knee Osteoarthritis (ExoOA-1)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad de los Andes, Chile"
                        ],
                        "OrgStudyId": [
                              "C4C060921"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 175,
                        "MaximumAge": [
                              "14 Years"
                        ],
                        "MinimumAge": [
                              "4 Years"
                        ],
                        "NCTId": [
                              "NCT03795974"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluation of the Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic Stem Cells and Mesenchymal Stromal Cells in Patients With Spastic Cerebral Palsy on Developmental Function , A Clinical Trial phase2"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Tehran University of Medical Sciences"
                        ],
                        "OrgStudyId": [
                              "IRCT201706176907N13"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 176,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04723303"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Florida"
                        ],
                        "OrgStudyId": [
                              "DM/PM V2.0"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 177,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03258164"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Fat Transplantation Enriched With Expanded Adipose-derived Autologous Mesenchymal Stromal Cells in Cosmetic Breast Augmentation and Cosmetic Facial Filling"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Stemform"
                        ],
                        "OrgStudyId": [
                              "H-16046960"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 178,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02962661"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Randomized 3-Arm Trial With Standard of Care Alone vs Either Intravenous Infusion or Transendocardial Injection of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) Plus Standard of Care in Patients With Anthracycline-Associated Cardiomyopathy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "M.D. Anderson Cancer Center"
                        ],
                        "OrgStudyId": [
                              "2015-0835"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 179,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT04126603"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Impact of Semaglutide (Long Acting GLP1 Agonist) on Peripheral Blood Derived CD34+ Endothelial Cells (EPCs) and Subcutaneous Fat Derived Mesenchymal Stromal Cells ( MSCs) in Type 2 Diabetes Subjects"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "George Washington University"
                        ],
                        "OrgStudyId": [
                              "NCR191206"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 180,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "12 Years"
                        ],
                        "NCTId": [
                              "NCT01624701"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells: A Pilot Trial in Collaboration With the Massachusetts Institute of Technology"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Singapore General Hospital"
                        ],
                        "OrgStudyId": [
                              "2009/925/B"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 181,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03298763"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University College, London"
                        ],
                        "OrgStudyId": [
                              "UCL/14/0453"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 182,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT02209311"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Tissue Engineered Construction Based on a Synthetic Tricalcium Phosphate and Autologous Multipotent Mesenchymal Stromal Cells Obtained From Oral Mucosa"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation"
                        ],
                        "OrgStudyId": [
                              "RU-CCH-06-01-14"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 183,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04390139"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Prospective, Double-blind, Randomized, Parallel, Placebo-controlled Pilot Clinical Trial for the Evaluation of the Efficacy and Safety of Two Doses of WJ-MSC in Patients With Acute Respiratory Distress Syndrome Secondary to Infection by COVID-19"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Banc de Sang i Teixits"
                        ],
                        "OrgStudyId": [
                              "BST-COVID-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 184,
                        "MaximumAge": [
                              "50 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05553132"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Hip RECLAIM: A Phase I Safety and Feasibility Trial of REcycled CartiLage Auto/Allo IMplantation for the Treatment and Repair of Focal Hip Cartilage Defects"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "22-004639"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 185,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02017912"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study to Evaluate Safety and Efficacy of Transplantation of Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors (MSC-NTF) in Patients With ALS"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Brainstorm-Cell Therapeutics"
                        ],
                        "OrgStudyId": [
                              "BCT-001-US"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 186,
                        "MaximumAge": [
                              "50 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01606215"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Stem Cells in Rapidly Evolving Active Multiple Sclerosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Imperial College London"
                        ],
                        "OrgStudyId": [
                              "CRO1959"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 187,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "25 Years"
                        ],
                        "NCTId": [
                              "NCT05008588"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "PT. Prodia Stem Cell Indonesia"
                        ],
                        "OrgStudyId": [
                              "CT/STROKE/PSI/2021"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 188,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT00908856"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety of IV Autologous Mononuclear Cells and Marrow Stromal Cells After Stroke"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of California, Irvine"
                        ],
                        "OrgStudyId": [
                              "2003-3040"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 189,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03609905"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II Randomized, Controlled, Clinical Trial for Assessment of the Safety and Efficacy of Allogeneic Adipose Mesenchymal Stem Cells in Moderate to Severe Ulcerative Colitis Patients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Liaocheng People's Hospital"
                        ],
                        "OrgStudyId": [
                              "lcsrmyy-yp1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 190,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT03166865"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Liaocheng People's Hospital"
                        ],
                        "OrgStudyId": [
                              "lcsrmyygk"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 191,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT03028428"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Research on Intra-articular Injection of Human Autologous MSCs in Treatment of Knee OA"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Affiliated Hospital of Jiangsu University"
                        ],
                        "OrgStudyId": [
                              "AHJiangsuU-FSK-MSC-OA"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 192,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT00395200"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Adult Human Mesenchymal Stem Cells: a Neuroprotective Therapy for Multiple Sclerosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Cambridge"
                        ],
                        "OrgStudyId": [
                              "MRCRG44871"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 193,
                        "MaximumAge": [
                              "50 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01730547"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 1/2 Clinical Trial With Autologous Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Karolinska Institutet"
                        ],
                        "OrgStudyId": [
                              "MSC-MS"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 194,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04961658"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Northern Therapeutics"
                        ],
                        "OrgStudyId": [
                              "CT-GEM-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 195,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03799718"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 2 Open-label Multicenter Study to Evaluate the Safety and Efficacy of Repeated Administration of NurOwn\u00ae [Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors (NTF), MSC-NTF] Cells in Participants With Progressive MS"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Brainstorm-Cell Therapeutics"
                        ],
                        "OrgStudyId": [
                              "BCT-101-US"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 196,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "16 Years"
                        ],
                        "NCTId": [
                              "NCT03847844"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Cytopeutics\u00ae Umbilical Cord Mesenchymal Stem Cells (Cyto-MSC) for Patients With Grade II -IV Acute Graft-Versus-Host Disease: A Phase I/II Clinical Study"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Cytopeutics Sdn. Bhd."
                        ],
                        "OrgStudyId": [
                              "POD0030/CP/R"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 197,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02685098"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Indiana University"
                        ],
                        "OrgStudyId": [
                              "1505714405"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 198,
                        "MaximumAge": [
                              "30 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04061746"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Medical University of South Carolina"
                        ],
                        "OrgStudyId": [
                              "00085542"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 199,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03280056"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn\u00ae (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Brainstorm-Cell Therapeutics"
                        ],
                        "OrgStudyId": [
                              "BCT-002-US"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 200,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02812121"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Umbilical Cord Blood Derived Mesenchymal Stem Cells Infusion for HBV-Related Acute-on-Chronic Liver Failure: A Randomized Controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Sun Yat-sen University"
                        ],
                        "OrgStudyId": [
                              "UCBMSC"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 201,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT01446614"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase\u2160/\u2161Trial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Parkinson's Disease."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangzhou General Hospital of Guangzhou Military Command"
                        ],
                        "OrgStudyId": [
                              "HM-2011-10"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 202,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "16 Years"
                        ],
                        "NCTId": [
                              "NCT01446640"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase\u2160/\u2161Trial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Spinal Cord Injury."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangzhou General Hospital of Guangzhou Military Command"
                        ],
                        "OrgStudyId": [
                              "HM-2011-09"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 203,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "16 Years"
                        ],
                        "NCTId": [
                              "NCT01305694"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase\u2160/\u2161Trial of Bone Marrow Derived Mesenchymal Stem Cell Transplantation From Related Donor to Patients With Relapsed/Refractory Aplastic Anemia."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangzhou General Hospital of Guangzhou Military Command"
                        ],
                        "OrgStudyId": [
                              "HM-2010-16"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 204,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04432545"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton\u00b4s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad de la Sabana"
                        ],
                        "OrgStudyId": [
                              "2019-10"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 205,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02249676"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Mesenchymal Stem Cells for the Treatment of Progressive and Refractory Neuromyelitis Optica Spectrum Disorders: an Open-label Phase 2a Proof-of-concept Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Tianjin Medical University General Hospital"
                        ],
                        "OrgStudyId": [
                              "IRB2013-055-02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 206,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "16 Years"
                        ],
                        "NCTId": [
                              "NCT03905824"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Randomized, Multicentric, Prospective, Double-blind Study: Effectiveness of Adding Allogenic Stem Cells to a Platelet-poor Plasma Scaffold After Arthroscopic Debridement and Microfractures in Patients With Osteochondral Lesions of the Talus"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Chile"
                        ],
                        "OrgStudyId": [
                              "OLT Protocol"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 207,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04865107"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Ottawa Hospital Research Institute"
                        ],
                        "OrgStudyId": [
                              "CIRCA-19 RCT"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 208,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02525432"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Multicenter Trial of Autologous Bone Marrow Mononuclear Cells for the Treatment of Adult Severe Traumatic Brain Injury"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The University of Texas Health Science Center, Houston"
                        ],
                        "OrgStudyId": [
                              "HSC-MS-16-0283"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 209,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02846883"
                        ],
                        "NCTIdAlias": [
                              "NCT02843854"
                        ],
                        "OfficialTitle": [
                              "Mesenchymal Stem Cells Induce Regulatory T Cells in Patients With Aortic Aneurysm"
                        ],
                        "OrgClass": [
                              "FED"
                        ],
                        "OrgFullName": [
                              "VA Office of Research and Development"
                        ],
                        "OrgStudyId": [
                              "CLNB-06-15F"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 210,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03682315"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Algae-derived Hydroxyapatite Behaviour as Bone Biomaterial in Comparison to Anorganic Bovine Bone. A Randomised Split-mouth Human Study."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad de Granada"
                        ],
                        "OrgStudyId": [
                              "307CEIH2017"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 211,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT02770430"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II, Randomized Study to Evaluate the Human Mesenchymal Stem Cells as a First-line Treatment for aGVHD in Patients Steroids Resistant."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Hospital de Clinicas de Porto Alegre"
                        ],
                        "OrgStudyId": [
                              "12-0407"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 212,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03797963"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Split-mouth Randomized Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad de Granada"
                        ],
                        "OrgStudyId": [
                              "480CEIH2018"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 213,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "14 Years"
                        ],
                        "NCTId": [
                              "NCT05152160"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Shenzhen University General Hospital"
                        ],
                        "OrgStudyId": [
                              "HEM-ONCO-014"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 214,
                        "MaximumAge": [
                              "50 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02482194"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Transplantation of Bone Marrow Mesenchymal Stem Cells in Patients of Spinal Cord Injury-Phase I Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "National Institute of Blood and Marrow Transplant (NIBMT), Pakistan"
                        ],
                        "OrgStudyId": [
                              "AFBMTC-SCI-2013"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 215,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04602442"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Extended Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Two-Sided Pneumonia"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "State-Financed Health Facility \"Samara Regional Medical Center Dinasty\""
                        ],
                        "OrgStudyId": [
                              "COVID-19 EXO Extended"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 216,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04491240"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Two-Sided Pneumonia"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "State-Financed Health Facility \"Samara Regional Medical Center Dinasty\""
                        ],
                        "OrgStudyId": [
                              "COVID-19 EXO"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [
                              "Increase in body temperature after each inhalation.",
                              "Allergic reactions in the form of Quincke's disease, rash, seizures were assessed after each inhalation.",
                              "bronchospasm for inhalation after the procedure were assessed after inhalation"
                        ],
                        "OtherEventOrganSystem": [
                              "Injury, poisoning and procedural complications",
                              "Immune system disorders",
                              "Respiratory, thoracic and mediastinal disorders"
                        ],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 217,
                        "MaximumAge": [
                              "45 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02037204"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Instant MSC Product Accompanying Autologous Chondron Transplantation (IMPACT): Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "UMC Utrecht"
                        ],
                        "OrgStudyId": [
                              "IMPACT"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Musculoskeletal and connective tissue disorders"
                        ],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 218,
                        "MaximumAge": [
                              "45 Years"
                        ],
                        "MinimumAge": [
                              "25 Years"
                        ],
                        "NCTId": [
                              "NCT00731744"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Generation of Dendritic Cell Precursors From Cord Blood Stem Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "National Taiwan University Hospital"
                        ],
                        "OrgStudyId": [
                              "200706003R"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 219,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT03795649"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Sisters of Mercy University Hospital"
                        ],
                        "OrgStudyId": [
                              "EP-12939/18-1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 220,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03918655"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "MIF : a New Target to Eradicate the Pre-leukemic Clone in Acute Myeloid Leukemia"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Assistance Publique - H\u00f4pitaux de Paris"
                        ],
                        "OrgStudyId": [
                              "PRT-K16055"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 221,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "16 Years"
                        ],
                        "NCTId": [
                              "NCT02696876"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy of a Novel Synovium Brushing Method for Endogenous Mesenchymal Stem Cells Mobilisation During Knee Joint Microfracture for Cartilage Repair."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Leeds"
                        ],
                        "OrgStudyId": [
                              "RR15/173"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 222,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03745417"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Efficacy and Safety of Expanded Umbilical Cord Mesenchymal Stem Cells On Patients With Moderate to Severe Psoriasis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2018-11"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 223,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04482699"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I/Phase II Trial of Allogeneic Hybrid TREG/Th2 Cell (RAPA-501-ALLO) Therapy for COVID-19-Related ARDS"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Rapa Therapeutics LLC"
                        ],
                        "OrgStudyId": [
                              "RAPA-501-ALLO-COVID-19"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 224,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03265613"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2017-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 225,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03392311"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Efficacy and Safety of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2016-04-02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 226,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04275024"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Patients With Moderate to Severe Psoriasis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2016-05-02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 227,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05086939"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Fundaci\u00f3n Instituto de Estudios de Ciencias de la Salud de Castilla y Le\u00f3n"
                        ],
                        "OrgStudyId": [
                              "ARTROCELL"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 228,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02338271"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy Study of Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Bundang CHA Hospital"
                        ],
                        "OrgStudyId": [
                              "ADMSC-DD-Han"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 229,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT03794622"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Effect of Autologous Bone Marrow Concentration on Femoral Shaft Fracture Union"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Show Chwan Memorial Hospital"
                        ],
                        "OrgStudyId": [
                              "RD106049"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 230,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT03793530"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Use of Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery: A Randomized Control Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Show Chwan Memorial Hospital"
                        ],
                        "OrgStudyId": [
                              "RD106050"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 231,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT03792594"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Effect of Autologous Bone Marrow Concentration Combined With Arthroscopy for Rotator Cuff Tear"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Show Chwan Memorial Hospital"
                        ],
                        "OrgStudyId": [
                              "RD106055"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 232,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT03787329"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Effect of Autologous Bone Marrow Concentration Combined With Core Decompression for Avascular Necrosis of Femoral Head"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Show Chwan Memorial Hospital"
                        ],
                        "OrgStudyId": [
                              "RD-106057"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 233,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02240823"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 1 Study. Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Odense University Hospital"
                        ],
                        "OrgStudyId": [
                              "2013-Afd-L"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 234,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05066334"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Intervertebral Disc Regeneration Mediated by Autologous Mesenchymal Stem/Stromal Cells Intradiscal Injection: a Phase IIB Randomized Clinical Trial - DREAM Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Campus Bio-Medico University"
                        ],
                        "OrgStudyId": [
                              "DREAM (GR - 2018-12367168)"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 235,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03103295"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy Study of Traumatic Bone Defects Treatment With Use of 3D Tissue Engineered Equivalent."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "A.A. Partners, LLC"
                        ],
                        "OrgStudyId": [
                              "MSC-P2-14"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 236,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04759105"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Mesenchymal Stem/Stromal Cells for the Treatment of Workers Affected by Chronic Low Back Pain Due to Multilevel InterVErtebral Disc Degeneration: a Phase IIB Randomized Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Campus Bio-Medico University"
                        ],
                        "OrgStudyId": [
                              "ACTIVE trial_(BRIC2018-ID03)"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 237,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01993368"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Centre Hospitalier Universitaire de Nice"
                        ],
                        "OrgStudyId": [
                              "13-PP-07"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 238,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT03369457"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Analysis of the Osteogenic Potential of Multipotent Cells From Different Anatomical Regions in Hip Replacement Surgery"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Istituto Ortopedico Galeazzi"
                        ],
                        "OrgStudyId": [
                              "EMPHA"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 239,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT03325322"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "16-010521"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 240,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04519671"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The Cleveland Clinic"
                        ],
                        "OrgStudyId": [
                              "20-1020"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 241,
                        "MaximumAge": [
                              "99 Years"
                        ],
                        "MinimumAge": [
                              "4 Years"
                        ],
                        "NCTId": [
                              "NCT02379442"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Pilot Study of Early Treatment of Acute Graft Versus Host Disease With Bone Marrow- Derived Mesenchymal Stem Cells and Corticosteroids: Correlation of Disease Severity and Response With Biomarkers"
                        ],
                        "OrgClass": [
                              "NIH"
                        ],
                        "OrgFullName": [
                              "National Institutes of Health Clinical Center (CC)"
                        ],
                        "OrgStudyId": [
                              "150088"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 242,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05054803"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Randomized, Double-blind, Placebo-controlled, Parallel, 2-arms Clinical Trial to Assess the Safety and Efficacy of Intrathecal Administration of WJ-MSC in Chronic Traumatic Cervical Incomplete Spinal Cord Injury"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Banc de Sang i Teixits"
                        ],
                        "OrgStudyId": [
                              "BST-SCI-02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 243,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04785027"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis: a Pilot Study for a Randomized Controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2020-01-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 244,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04136743"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Ultrasound-Guided Treatments for Chronic Shoulder Pain in Wheelchair Users With Spinal Cord Injury: A Randomized Controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Kessler Foundation"
                        ],
                        "OrgStudyId": [
                              "R-1066-19"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 245,
                        "MaximumAge": [
                              "45 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04274543"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Use of Autologous, Micro-Fragmented Adipose Tissue to Treat Meniscal Injuries in Active Duty Military Personnel"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Kessler Foundation"
                        ],
                        "OrgStudyId": [
                              "R-1065-19"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 246,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03874572"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Open Label Study Evaluating the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia in Previous Oropharynx Cancer Patients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Rigshospitalet, Denmark"
                        ],
                        "OrgStudyId": [
                              "CVB2018-2"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 247,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT01051882"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/II, Open Label Study to Evaluate Safety, Tolerability and Therapeutic Effects of Transplantation of Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Brainstorm-Cell Therapeutics"
                        ],
                        "OrgStudyId": [
                              "MSC-NTF-001-HMO-CTIL"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 248,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04461925"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic Multipotent Mesenchymal Stem Cells of the Placenta and Umbilical Cord"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Institute of Cell Therapy"
                        ],
                        "OrgStudyId": [
                              "#4/24.04.2020"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 249,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04174547"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "An Integrated European Platform to Conduct Translational Studies in Myelodysplastic Syndromes Based on the EuroBloodNet Infrastructure"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Istituto Clinico Humanitas"
                        ],
                        "OrgStudyId": [
                              "TRS-2018-00000745"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 250,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05187936"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University Hospital, Montpellier"
                        ],
                        "OrgStudyId": [
                              "RECHMPL21_0640"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 251,
                        "MaximumAge": [
                              "99 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03876197"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Follow-up Study of Safety and Efficacy in Subjects Who Participated in the Study of Intraglandular Mesenchymal Stem Cells in Patients With Radiation-induced Hyposalivation and Xerostomia (MESRIX)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Rigshospitalet, Denmark"
                        ],
                        "OrgStudyId": [
                              "CVB2019-1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 252,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03555773"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Complex Crohns' Perianal Fistulas by Local Injection of Autologous and Micro-fragmented Adipose Tissue"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "IRCCS Azienda Ospedaliero-Universitaria di Bologna"
                        ],
                        "OrgStudyId": [
                              "Lipogems-crohn2"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 253,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02619734"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Efficacy and Safety of Autologous Bone Marrow Stem Cells Infusion for Treatment of Chronic Leg Ulcer in Sickle Cell Disease Patients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Federal University of Bahia"
                        ],
                        "OrgStudyId": [
                              "11738"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 254,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04883502"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Direction Centrale du Service de Sant\u00e9 des Arm\u00e9es"
                        ],
                        "OrgStudyId": [
                              "2019PPRC03"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 255,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT04869761"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Mesenchymal Stem Cell Therapy in Patients With Chronic Kidney Disease: A Phase I Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "20-008380"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 256,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01144962"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Leiden University Medical Center"
                        ],
                        "OrgStudyId": [
                              "P10.102"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 257,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03167138"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Chronic Shoulder Pain in Persons With Spinal Cord Injury Using Injection With Autologous Micro-Fragmented Adipose Tissue Under Ultrasound Guidance"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Kessler Foundation"
                        ],
                        "OrgStudyId": [
                              "R-957-17"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 258,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01892514"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Combined Treatment of Early and Advanced Osteonecrosis of the Femoral Head With Core Decompression and Grafting With Demineralized Bone Matrix (DBM) or Homologous Lyophilized Bone Chips (LBC) Together With Platelet-rich-fibrin (PRF) and Concentrated Bone Marrow (CBM)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Istituto Ortopedico Rizzoli"
                        ],
                        "OrgStudyId": [
                              "AVN-13"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 259,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "60 Years"
                        ],
                        "NCTId": [
                              "NCT05488093"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluation of Movement and Muscular Alterations in Subjects With Severe Knee Osteoarthritis Who Are to Receive a Total Knee Replacement"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University Hospital, Montpellier"
                        ],
                        "OrgStudyId": [
                              "RECHMPL22_0051"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 260,
                        "MaximumAge": [
                              "58 Years"
                        ],
                        "MinimumAge": [
                              "16 Years"
                        ],
                        "NCTId": [
                              "NCT03102879"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Encapsulated Mesenchymal Stem Cells for Endodontic Treatment of Permanent Teeth With Apical Lesion: a Controlled Clinical Trial."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad de los Andes, Chile"
                        ],
                        "OrgStudyId": [
                              "RPD-8-16"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 261,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02448121"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment for Hip, Knee, Ankle and Shoulder Osteonecrosis With Autologous Mononuclear Cells Transplantation in People With Sickle Cell Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Federal University of Bahia"
                        ],
                        "OrgStudyId": [
                              "CAAE 25000039812/2005-99"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 262,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT01777646"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase IIa, Open Label, Dose-escalating Clinical Study to Evaluate the Safety, Tolerability and Therapeutic Effects of Transplantation of Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Brainstorm-Cell Therapeutics"
                        ],
                        "OrgStudyId": [
                              "MSC-NTF-002-HMO-CTIL"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 263,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "25 Years"
                        ],
                        "NCTId": [
                              "NCT03164083"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells and Stromal Vascular Fraction Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "SCARM Institute, Tabriz, Iran"
                        ],
                        "OrgStudyId": [
                              "SCARM-Osteoarthritis-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 264,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "45 Years"
                        ],
                        "NCTId": [
                              "NCT03840343"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "18-002423"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 265,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04453111"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Institute of Cell Therapy"
                        ],
                        "OrgStudyId": [
                              "#7/09.26.2018"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 266,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "60 Years"
                        ],
                        "NCTId": [
                              "NCT04919135"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Vinmec Research Institute of Stem Cell and Gene Technology"
                        ],
                        "OrgStudyId": [
                              "VinmecISC2111"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 267,
                        "MaximumAge": [
                              "35 Years"
                        ],
                        "MinimumAge": [
                              "16 Years"
                        ],
                        "NCTId": [
                              "NCT03920397"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogenic Adipose Derived Mesenchymal Stem Cells and Vitamin D Supplementation in Patients With Recent-onset Type 1 Diabetes Mellitus"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidade Federal do Rio de Janeiro"
                        ],
                        "OrgStudyId": [
                              "Nutro_MesenchymalStemCells_DM1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 268,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "35 Years"
                        ],
                        "NCTId": [
                              "NCT01849159"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Federal Research Clinical Center of Federal Medical & Biological Agency, Russia"
                        ],
                        "OrgStudyId": [
                              "MSC-HYP-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 269,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02326935"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Proposal for a Non-randomized, Patient Sponsored, Multi-center Study Studying the Impact and Safety of the Utilization of Culture Expanded Autologous, Adipose-derived Mesenchymal Stem Cells Deployed Via Intravenous Injection for the Treatment of Multiple Sclerosis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "American CryoStem Corporation"
                        ],
                        "OrgStudyId": [
                              "CRYO-MS-ADSC-006"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 270,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02145897"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intramuscular and Intravenous Administration of Autologous ADMSCS for Treatment of Critical Limb Ischemia (CLI)."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Kasiak Research Pvt. Ltd."
                        ],
                        "OrgStudyId": [
                              "KRPL/CLI/11-12/001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 271,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT00186914"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation: A Phase I Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "St. Jude Children's Research Hospital"
                        ],
                        "OrgStudyId": [
                              "STOD"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 272,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT03818737"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Randomized Multicenter Phase 3 Single-blind Trial Comparing the Efficacy of Corticosteroid Control to Mesenchymal Stem Cell Preparations From Autologous Bone Marrow Concentrate (BMAC), Adipose-derived Stem Cells in the Form of Stromal Vascular Fraction (SVF), and Third-party Human Mesenchymal Stem Cells Manufactured From Umbilical Cord Tissue for the Treatment of Unilateral Knee Osteoarthritis (OA)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Emory University"
                        ],
                        "OrgStudyId": [
                              "IRB00108046"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 273,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05305833"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Stem Cells Transplantation for Temporomandibular Joint Disease: Phase I/II Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "TC Erciyes University"
                        ],
                        "OrgStudyId": [
                              "2021/584"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 274,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04223622"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Secretome From Mesenchymal Stem/Stromal Cells on Human Osteochondral Explants: Cocktail of Factors Secreted by Adipose-derived Stromal Cells (ASC) for the Treatment of Osteoarthritis and/or for Articular Regeneration"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Istituto Ortopedico Galeazzi"
                        ],
                        "OrgStudyId": [
                              "ASC-OA"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 275,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02492490"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effect of Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cell in Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Randomized Controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Fuzhou General Hospital"
                        ],
                        "OrgStudyId": [
                              "SVF-DCD"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 276,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04351932"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Randomized Non Blind Controlled Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad Catolica Santiago de Guayaquil"
                        ],
                        "OrgStudyId": [
                              "UCSantiagodeGuayaquil001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 277,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "35 Years"
                        ],
                        "NCTId": [
                              "NCT00781872"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Explorative Trial to Investigate the Safety and Clinical Effects of Autologous Mesenchymal Bone Marrow Stem Cells (MSC) Following Their Intrathecal and Intravenous Administration in Severe Cases of Multiple Sclerosis (MS)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Hadassah Medical Organization"
                        ],
                        "OrgStudyId": [
                              "MS22MSC-HMO-CTIL"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 278,
                        "MaximumAge": [
                              "18 Years"
                        ],
                        "MinimumAge": [
                              "8 Weeks"
                        ],
                        "NCTId": [
                              "NCT02957552"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Tolerance of Immunomodulating Therapy With Donor-specific Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation, a 24-month, Non-randomized, Open-label, Prospective, Single-center Pilot Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University Hospital Tuebingen"
                        ],
                        "OrgStudyId": [
                              "MYSTEP1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 279,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT04433104"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Human Umbilical Cord-derived Mesenchymal Stem/Stromal Cells for Chronic Obstructive Pulmonary Disease (COPD): Study Protocol for a Matched Case-control, Phase I/II Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Vinmec Research Institute of Stem Cell and Gene Technology"
                        ],
                        "OrgStudyId": [
                              "VinmecISC1916"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 280,
                        "MaximumAge": [
                              "45 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02442817"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Linagliptin and Mesenchymal Stem Cells: A Pilot Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of Nevada, Reno"
                        ],
                        "OrgStudyId": [
                              "LING-1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 281,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT02135380"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intravenous Autologous Adipose Derived Adult Stem Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF)."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Kasiak Research Pvt. Ltd."
                        ],
                        "OrgStudyId": [
                              "KRPL/IPF/11-12/002"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 282,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT05280002"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Outcomes of Single Intra-articular Injection of Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh"
                        ],
                        "OrgStudyId": [
                              "BSMMU/2018/25"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 283,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04821479"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Clinical Effects of Repeated Intrathecal Injections of Autologous Mesenchymal Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Hadassah Medical Organization"
                        ],
                        "OrgStudyId": [
                              "0208-16-HMO"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 284,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02975960"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Adipose Tissue-derived Mesenchymal Stem Cells for Cell-based Therapy in the Treatment of Systemic Sclerosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The Catholic University of Korea"
                        ],
                        "OrgStudyId": [
                              "KC16TISI0343"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 285,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "45 Years"
                        ],
                        "NCTId": [
                              "NCT02749448"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Effect of Autologous Adipose Mesenchymal Stem Cells in Treatment of Airway Injury in Patients Exposed to Sulfur Mustard"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Baqiyatallah Medical Sciences University"
                        ],
                        "OrgStudyId": [
                              "IRCT2015110524890N1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 286,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT05484856"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Prospective Single Centre, Open Label, Single Arm Clinical Study for Autologous Adipose Tissue Derived ADSCSs in Treatment of Patients With Osteoarthritis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Dr. Himanshu Bansal Foundation"
                        ],
                        "OrgStudyId": [
                              "AAH/CLINICALTRIAL/01/2016"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 287,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01548092"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II Clinical Trial to Study the Feasibility and Safety of Stromal Vascular Derived From Adipose Tissue for the Treatment of Recto-vaginal Fistula"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Instituto de Investigaci\u00f3n Hospital Universitario La Paz"
                        ],
                        "OrgStudyId": [
                              "EC10-343"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 288,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "25 Years"
                        ],
                        "NCTId": [
                              "NCT04340284"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Retrospective Study to Analyze Safety and Efficacy of Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Dr. Himanshu Bansal Foundation"
                        ],
                        "OrgStudyId": [
                              "HimanshubansalFoundation"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 289,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04377334"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Prospective Phase II Study: MSCs in Inflammation-Resolution Programs of SARS-CoV-2 Induced ARDS"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University Hospital Tuebingen"
                        ],
                        "OrgStudyId": [
                              "RESCOVID"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 290,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01795950"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Safety and Pharmacodynamic Study of Intravenous Infusion of PLX-PAD Cells in Patients With PAH"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "United Therapeutics"
                        ],
                        "OrgStudyId": [
                              "PLX-PH-101"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 291,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT00913289"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Kanazawa University"
                        ],
                        "OrgStudyId": [
                              "675"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 292,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02893306"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 2 Study of Intravenous Administration of Allogeneic Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad del Desarrollo"
                        ],
                        "OrgStudyId": [
                              "DMT1-MSC"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 293,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02467387"
                        ],
                        "NCTIdAlias": [
                              "NCT02123706"
                        ],
                        "OfficialTitle": [
                              "A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "CardioCell LLC"
                        ],
                        "OrgStudyId": [
                              "STEM-104-M-CHF"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "General disorders",
                              "Investigations",
                              "Infections and infestations",
                              "Metabolism and nutrition disorders",
                              "Nervous system disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Musculoskeletal and connective tissue disorders"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA (17.0)",
                              "MedDRA (17.0)",
                              "MedDRA (17.0)",
                              "MedDRA (17.0)",
                              "MedDRA (17.0)",
                              "MedDRA (17.0)",
                              "MedDRA (17.0)"
                        ]
                  },
                  {
                        "Rank": 294,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT01062750"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Kanazawa University"
                        ],
                        "OrgStudyId": [
                              "1132"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 295,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03939741"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluation of Therapeutic Potential of Stromal Vascular Fraction (Autologous Adipose Derived Mesenchymal Stem Cell) Based Treatment for Chronic Kidney Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Bangladesh Laser & Cell Surgery Institute & Hospital"
                        ],
                        "OrgStudyId": [
                              "BangladeshLCS001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 296,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT03601234"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Application of Laparoscopy Combined With Endoscopy Surgery in the Treatment of Gastric Stromal Tumors"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "First Affiliated Hospital Xi'an Jiaotong University"
                        ],
                        "OrgStudyId": [
                              "XJYFY-2017W44"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 297,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT01709279"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Kanazawa University"
                        ],
                        "OrgStudyId": [
                              "1133"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 298,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03887208"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluation the Safety and Efficacy of the Treatment of Scars and Cutis Laxa Syndrome With the Use of Autologous (Fresh and Stored) Stem Cells Isolated From Adipose Tissue."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Medical University of Warsaw"
                        ],
                        "OrgStudyId": [
                              "2ABC Therapy"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 299,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "16 Years"
                        ],
                        "NCTId": [
                              "NCT03042143"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST): An Open Label Dose Escalation Phase 1 Trial Followed by a Randomised, Double-blind, Allocation Concealed, Placebo-controlled Trial."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Belfast Health and Social Care Trust"
                        ],
                        "OrgStudyId": [
                              "16154DMcA-AS"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 300,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04143048"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "The First Affiliated Hospital with Nanjing Medical University"
                        ],
                        "OrgStudyId": [
                              "2019-SR-358"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 301,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "24 Years"
                        ],
                        "NCTId": [
                              "NCT03726255"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Retrospective Evaluation of Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Instituto de Investigaci\u00f3n Sanitaria de la Fundaci\u00f3n Jim\u00e9nez D\u00edaz"
                        ],
                        "OrgStudyId": [
                              "EO166-18_FJD"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 302,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01468064"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Patients With Ischemic Stroke: a Randomized Controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Southern Medical University, China"
                        ],
                        "OrgStudyId": [
                              "ZJH-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 303,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01377870"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effect and Side Effect of Mesenchymal Stem Cell in Multiple Sclerosis"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royn-nerve-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 304,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04005989"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Hospital do Coracao"
                        ],
                        "OrgStudyId": [
                              "ADMIRE"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 305,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02622464"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Assistance Publique Hopitaux De Marseille"
                        ],
                        "OrgStudyId": [
                              "2015-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 306,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03963544"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (GIST) in a Real-life Setting: the METAGIST Observational Study"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Institut Bergoni\u00e9"
                        ],
                        "OrgStudyId": [
                              "IB2019-METAGIST"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 307,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT02763748"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "the Prospective, Randomized and Comparative Clinical Study of Laparoscopic and Endoscopic Cooperative Surgery in the Treatment of Gastrointestinal Stromal Tumor"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "First Affiliated Hospital Xi'an Jiaotong University"
                        ],
                        "OrgStudyId": [
                              "XJTU1AF-CRF-2015-019"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 308,
                        "MaximumAge": [
                              "89 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05453292"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Feasibility, Safety, and Efficacy of EUS-guided Thermal Radiofrequency Ablation in the Treatment of Gastrointestinal Stromal Tumors"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Instituto Ecuatoriano de Enfermedades Digestivas"
                        ],
                        "OrgStudyId": [
                              "IECED-05072022"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 309,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04614025"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Pluristem Ltd."
                        ],
                        "OrgStudyId": [
                              "PLX-COV-03"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 310,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "21 Years"
                        ],
                        "NCTId": [
                              "NCT05523011"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 1, Open-label Study to Determine Safety and Tolerability of the Topical Application of Mesenchymal Stem/Stromal Cell (MSC) Exosome Ointment to Treat Psoriasis in Healthy Volunteers"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Paracrine Therapeutics Dermatology Pte. Ltd."
                        ],
                        "OrgStudyId": [
                              "PTD2021P001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 311,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01172548"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Multi-center, Single Arm, Phase II Study of Adjuvant Imatinib (Glivec\u00ae) in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor ( GIST)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Novartis"
                        ],
                        "OrgStudyId": [
                              "CSTI571BIC08"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 312,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05270850"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Study on Autologous Stromal Vascular Fraction(SVF) Treatment for Benign Airway Stenosis and Respiratory Tract Fistula"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangzhou Institute of Respiratory Disease"
                        ],
                        "OrgStudyId": [
                              "20220210"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 313,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05385159"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Assistance Publique Hopitaux De Marseille"
                        ],
                        "OrgStudyId": [
                              "2020-53"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 314,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01874665"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor Following Failure of Prior Tyrosine Kinase Inhibitor Therapy"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Takeda"
                        ],
                        "OrgStudyId": [
                              "AP24534-12-202"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment",
                              "Non-systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Blood and lymphatic system disorders",
                              "Cardiac disorders",
                              "Endocrine disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Investigations",
                              "Investigations",
                              "Investigations",
                              "Investigations",
                              "Investigations",
                              "Investigations",
                              "Investigations",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Psychiatric disorders",
                              "Renal and urinary disorders",
                              "Reproductive system and breast disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Vascular disorders",
                              "Blood and lymphatic system disorders",
                              "Blood and lymphatic system disorders",
                              "Blood and lymphatic system disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Cardiac disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Investigations",
                              "Investigations",
                              "Investigations",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Nervous system disorders",
                              "Psychiatric disorders",
                              "Psychiatric disorders",
                              "Psychiatric disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Renal and urinary disorders",
                              "Reproductive system and breast disorders",
                              "Reproductive system and breast disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Vascular disorders",
                              "Vascular disorders",
                              "Vascular disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Eye disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Ear and labyrinth disorders",
                              "Ear and labyrinth disorders",
                              "Ear and labyrinth disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)",
                              "MedDRA (19.0)"
                        ]
                  },
                  {
                        "Rank": 315,
                        "MaximumAge": [
                              "99 Years"
                        ],
                        "MinimumAge": [
                              "3 Years"
                        ],
                        "NCTId": [
                              "NCT03109301"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II Trial of the Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)"
                        ],
                        "OrgClass": [
                              "NIH"
                        ],
                        "OrgFullName": [
                              "National Institutes of Health Clinical Center (CC)"
                        ],
                        "OrgStudyId": [
                              "170084"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 316,
                        "MaximumAge": [
                              "90 Years"
                        ],
                        "MinimumAge": [
                              "10 Years"
                        ],
                        "NCTId": [
                              "NCT04269941"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinicopathological Characteristics and Prognostic Factors of Gastrointestinal Stromal Tumors Located in the Stomach in Tunisian Patients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universit\u00e9 de Sousse"
                        ],
                        "OrgStudyId": [
                              "U23453"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 317,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01557543"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD With Depressed Left Ventricular Function"
                        ],
                        "OrgClass": [
                              "NIH"
                        ],
                        "OrgFullName": [
                              "National Institutes of Health Clinical Center (CC)"
                        ],
                        "OrgStudyId": [
                              "120078"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 318,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT04389450"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX PAD for the Treatment of Severe COVID-19"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Pluristem Ltd."
                        ],
                        "OrgStudyId": [
                              "PLX-COV-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 319,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT05081921"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Double Blind, Two Arms, Controlled Phase I/II Safety and Efficacy Study on MesoCellA-Ortho Tissue Engineered Product Intraarticularly Administrated in Adult Patients With Osteoarthrosis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Jagiellonian University"
                        ],
                        "OrgStudyId": [
                              "JU-BioMiStem-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 320,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02492308"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effect of Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cell in Living-Related Kidney Transplants: A Randomized Controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Fuzhou General Hospital"
                        ],
                        "OrgStudyId": [
                              "SVF-LR"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 321,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT01532076"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts Versus Acellular Bone Graft Substitutes for Augmentation in the Treatment of Proximal Humeral Fractures as Model for Fractures of Osteoporotic Bone - a Prospective Randomized First in Men Proof of Principle Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University Hospital, Basel, Switzerland"
                        ],
                        "OrgStudyId": [
                              "348/10"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 322,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT02884154"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Pusan National University Hospital"
                        ],
                        "OrgStudyId": [
                              "K_EUS_Study_1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 323,
                        "MaximumAge": [
                              "3 Years"
                        ],
                        "MinimumAge": [
                              "6 Months"
                        ],
                        "NCTId": [
                              "NCT04314687"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Umbilical Cord Mesenchymal Stem Cells and Conditioned Medium for Cerebral Palsy in Children"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "PT. Prodia Stem Cell Indonesia"
                        ],
                        "OrgStudyId": [
                              "CT/CP/02/2020"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 324,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02064062"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous Stem Cells in Achilles Tendinopathy"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University College, London"
                        ],
                        "OrgStudyId": [
                              "12/0419"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 325,
                        "MaximumAge": [
                              "81 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT00919958"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Study of Intramuscular (IM) Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia. PLX-PAD Are Mesenchymal-like Stromal Cells Derived From a Full Term Placenta. These Placental Adherent Stromal Cells (ASCs) Are Expanded in the Company's Proprietary PluriXTM 3D Bioreactor System. PLX Cells Are Immune Privileged and Possess Immunomodulatory Properties."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Pluristem Ltd."
                        ],
                        "OrgStudyId": [
                              "PLX-PAD 1202-1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 326,
                        "MaximumAge": [
                              "81 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT00951210"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Study of Intramuscular (IM) Injections of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia. PLX-PAD Are Mesenchymal-Like Stromal Cells Derived From a Full Term Placenta."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Pluristem Ltd."
                        ],
                        "OrgStudyId": [
                              "1202-2"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  }
            ]
      }
}